Anthony Welters insider trades
Open-market stock purchases and sales by Anthony Welters, Director at Gilead Sciences, Inc, from SEC Form 4 filings since Dec 31, 2009.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +170%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Sold | $462K |
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Sold | $685K |
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Sold | $504K |
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Sold | $1M |
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Bought (not open market) | — |
| Aug 26, 2026 | GILD Gilead Sciences, Inc | Bought (not open market) | — |
| May 1, 2026 | CG Carlyle Group Inc | Bought (not open market) | — |
| Apr 30, 2026 | GILD Gilead Sciences, Inc | Bought (not open market) | — |
| Apr 30, 2026 | GILD Gilead Sciences, Inc | Bought (not open market) | — |
| Nov 25, 2025 | CG Carlyle Group Inc | Sold (not open market) | — |
| Nov 25, 2025 | CG Carlyle Group Inc | Sold (not open market) | — |
Companies traded
- GILD Gilead Sciences, Inc: 4 sales, last Aug 26, 2026
- CG Carlyle Group Inc: 1 buy, last May 1, 2026
- L Loews Corp: 1 buy, 6 sales, last Mar 3, 2025
- BCR Bard C R Inc /nj/: 5 sales, last Dec 29, 2017
- WST West Pharmaceutical Services Inc: 2 sales, last Mar 31, 2016
- UNH Unitedhealth Group Inc: 7 sales, last Jun 5, 2012
- Q Qwest Communications International Inc: other filings, last Apr 1, 2011